Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms

The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. Lower median minimum inhibitory concentration...

Full description

Saved in:
Bibliographic Details
Published in:BMC research notes 2018-07, Vol.11 (1), p.497-497, Article 497
Main Authors: Chastain, Daniel B, King, S Travis, Stover, Kayla R
Format: Article
Language:English
Subjects:
Antibiotic
Antibiotics
Breakpoints
Care and treatment
Cefepime
Ceftriaxone
Ciprofloxacin
Drug dosages
Drug resistance
Health aspects
Laboratories
Multi-drug resistant
Multidrug resistance
Multidrug resistant organisms
Organisms
Pharmacodynamics
Pharmacokinetics
Research Note
Urinary tract infections
Urine
Urine concentration
Values
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3
cites cdi_FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3
container_end_page 497
container_issue 1
container_start_page 497
container_title BMC research notes
container_volume 11
creator Chastain, Daniel B
King, S Travis
Stover, Kayla R
description The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest to Vitek . All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest . Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing.
doi_str_mv 10.1186/s13104-018-3599-8
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_bf4dd990fb6d45278ce93368ab67028c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A547140745</galeid><doaj_id>oai_doaj_org_article_bf4dd990fb6d45278ce93368ab67028c</doaj_id><sourcerecordid>A547140745</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3</originalsourceid><addsrcrecordid>eNptkl9r1jAUxosobk4_gDdS8EYvOpOmSRMvhDH888JgIMPbkKRpl3dt8pqk4q721XdeO-cqIxctJ7_nOXmSUxSvMTrGmLMPCROMmgphXhEqRMWfFIe4paxCFKGnD_4PihcpbRFimHP8vDggCNWCYXxY3Hy3-dL5K-eHco7Oq3hdKp-ddiE7U-po1dUuOJ_TR6ir8Tq5VIb-MdYEb6zPUWUXfCpzKDOocznNY3ZdnIcyWlBnkJQhDsq7NKWXxbNejcm-uvseFRdfPl-cfqvOzr9uTk_OKkOR4JUWrOnqllNrbEN7qlrUd5orArl7zeqaKmEpRzUyXAvYx7CMsYz2tiOaHBWbxbYLait30U1weBmUk38KcBypIoQYrdR903VCILDtGgo9jRWEMK40a1HNDXh9Wrx2s55st2QeV6brHe8u5RB-SYYo4YSBwbs7gxh-zjZlOblk7Dgqb8OcZI1aAh0J5oC-_Q_dhjnCOwDVCkzqmrfNP2pQEMD5PkBfszeVJ7RpcYPahgJ1_AgFq7OTg8ezvYP6SvB-JQAm2995UHNKcnP-Y83ihTUxpBRtf38fGMn9sMplWCUMq9wPq9yHe_PwIu8Vf6eT3AIFc-cZ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791322874</pqid></control><display><type>article</type><title>Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Chastain, Daniel B ; King, S Travis ; Stover, Kayla R</creator><creatorcontrib>Chastain, Daniel B ; King, S Travis ; Stover, Kayla R</creatorcontrib><description>The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest to Vitek . All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest . Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing.</description><identifier>ISSN: 1756-0500</identifier><identifier>EISSN: 1756-0500</identifier><identifier>DOI: 10.1186/s13104-018-3599-8</identifier><identifier>PMID: 30029611</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Antibiotic ; Antibiotics ; Breakpoints ; Care and treatment ; Cefepime ; Ceftriaxone ; Ciprofloxacin ; Drug dosages ; Drug resistance ; Health aspects ; Laboratories ; Multi-drug resistant ; Multidrug resistance ; Multidrug resistant organisms ; Organisms ; Pharmacodynamics ; Pharmacokinetics ; Research Note ; Urinary tract infections ; Urine ; Urine concentration ; Values</subject><ispartof>BMC research notes, 2018-07, Vol.11 (1), p.497-497, Article 497</ispartof><rights>COPYRIGHT 2018 BioMed Central Ltd.</rights><rights>2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3</citedby><cites>FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053836/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2791322874?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30029611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chastain, Daniel B</creatorcontrib><creatorcontrib>King, S Travis</creatorcontrib><creatorcontrib>Stover, Kayla R</creatorcontrib><title>Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms</title><title>BMC research notes</title><addtitle>BMC Res Notes</addtitle><description>The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest to Vitek . All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest . Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing.</description><subject>Antibiotic</subject><subject>Antibiotics</subject><subject>Breakpoints</subject><subject>Care and treatment</subject><subject>Cefepime</subject><subject>Ceftriaxone</subject><subject>Ciprofloxacin</subject><subject>Drug dosages</subject><subject>Drug resistance</subject><subject>Health aspects</subject><subject>Laboratories</subject><subject>Multi-drug resistant</subject><subject>Multidrug resistance</subject><subject>Multidrug resistant organisms</subject><subject>Organisms</subject><subject>Pharmacodynamics</subject><subject>Pharmacokinetics</subject><subject>Research Note</subject><subject>Urinary tract infections</subject><subject>Urine</subject><subject>Urine concentration</subject><subject>Values</subject><issn>1756-0500</issn><issn>1756-0500</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl9r1jAUxosobk4_gDdS8EYvOpOmSRMvhDH888JgIMPbkKRpl3dt8pqk4q721XdeO-cqIxctJ7_nOXmSUxSvMTrGmLMPCROMmgphXhEqRMWfFIe4paxCFKGnD_4PihcpbRFimHP8vDggCNWCYXxY3Hy3-dL5K-eHco7Oq3hdKp-ddiE7U-po1dUuOJ_TR6ir8Tq5VIb-MdYEb6zPUWUXfCpzKDOocznNY3ZdnIcyWlBnkJQhDsq7NKWXxbNejcm-uvseFRdfPl-cfqvOzr9uTk_OKkOR4JUWrOnqllNrbEN7qlrUd5orArl7zeqaKmEpRzUyXAvYx7CMsYz2tiOaHBWbxbYLait30U1weBmUk38KcBypIoQYrdR903VCILDtGgo9jRWEMK40a1HNDXh9Wrx2s55st2QeV6brHe8u5RB-SYYo4YSBwbs7gxh-zjZlOblk7Dgqb8OcZI1aAh0J5oC-_Q_dhjnCOwDVCkzqmrfNP2pQEMD5PkBfszeVJ7RpcYPahgJ1_AgFq7OTg8ezvYP6SvB-JQAm2995UHNKcnP-Y83ihTUxpBRtf38fGMn9sMplWCUMq9wPq9yHe_PwIu8Vf6eT3AIFc-cZ</recordid><startdate>20180720</startdate><enddate>20180720</enddate><creator>Chastain, Daniel B</creator><creator>King, S Travis</creator><creator>Stover, Kayla R</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20180720</creationdate><title>Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms</title><author>Chastain, Daniel B ; King, S Travis ; Stover, Kayla R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibiotic</topic><topic>Antibiotics</topic><topic>Breakpoints</topic><topic>Care and treatment</topic><topic>Cefepime</topic><topic>Ceftriaxone</topic><topic>Ciprofloxacin</topic><topic>Drug dosages</topic><topic>Drug resistance</topic><topic>Health aspects</topic><topic>Laboratories</topic><topic>Multi-drug resistant</topic><topic>Multidrug resistance</topic><topic>Multidrug resistant organisms</topic><topic>Organisms</topic><topic>Pharmacodynamics</topic><topic>Pharmacokinetics</topic><topic>Research Note</topic><topic>Urinary tract infections</topic><topic>Urine</topic><topic>Urine concentration</topic><topic>Values</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chastain, Daniel B</creatorcontrib><creatorcontrib>King, S Travis</creatorcontrib><creatorcontrib>Stover, Kayla R</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC research notes</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chastain, Daniel B</au><au>King, S Travis</au><au>Stover, Kayla R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms</atitle><jtitle>BMC research notes</jtitle><addtitle>BMC Res Notes</addtitle><date>2018-07-20</date><risdate>2018</risdate><volume>11</volume><issue>1</issue><spage>497</spage><epage>497</epage><pages>497-497</pages><artnum>497</artnum><issn>1756-0500</issn><eissn>1756-0500</eissn><abstract>The present study analyzed whether renally eliminated antibiotics achieve sufficient urinary concentrations based on their pharmacokinetic/pharmacodynamic principles to effectively eradicate organisms deemed resistant by automated susceptibility testing. Lower median minimum inhibitory concentrations against enterobacteriaceae were noted for ceftriaxone, cefepime, and doripenem when comparing Etest to Vitek . All Pseudomonas aeruginosa isolates were susceptible to cefepime, ciprofloxacin, and doripenem with both susceptibility methods, but higher median minimum inhibitory concentrations were observed with Etest . Urine concentrations/time profiles were calculated for standard doses of ceftriaxone, cefepime, doripenem, and ciprofloxacin. The data presented in the current study suggests high urine concentrations of antibiotics may effectively eradicate bacteria which were determined to be resistant per in vitro susceptibility testing.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>30029611</pmid><doi>10.1186/s13104-018-3599-8</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1756-0500
ispartof BMC research notes, 2018-07, Vol.11 (1), p.497-497, Article 497
issn 1756-0500
1756-0500
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_bf4dd990fb6d45278ce93368ab67028c
source PubMed (Medline); Publicly Available Content Database
subjects Antibiotic
Antibiotics
Breakpoints
Care and treatment
Cefepime
Ceftriaxone
Ciprofloxacin
Drug dosages
Drug resistance
Health aspects
Laboratories
Multi-drug resistant
Multidrug resistance
Multidrug resistant organisms
Organisms
Pharmacodynamics
Pharmacokinetics
Research Note
Urinary tract infections
Urine
Urine concentration
Values
title Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T11%3A10%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rethinking%20urinary%20antibiotic%20breakpoints:%20analysis%20of%20urinary%20antibiotic%20concentrations%20to%20treat%20multidrug%20resistant%20organisms&rft.jtitle=BMC%20research%20notes&rft.au=Chastain,%20Daniel%20B&rft.date=2018-07-20&rft.volume=11&rft.issue=1&rft.spage=497&rft.epage=497&rft.pages=497-497&rft.artnum=497&rft.issn=1756-0500&rft.eissn=1756-0500&rft_id=info:doi/10.1186/s13104-018-3599-8&rft_dat=%3Cgale_doaj_%3EA547140745%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5098-b964d2785ece45f5a70fdb8a3359fb6225a9e58020c8b9f5a1a1acce65fed3b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791322874&rft_id=info:pmid/30029611&rft_galeid=A547140745&rfr_iscdi=true